Swipe tables sideways to see all columns.
Research findings
Cohort structure analysis
Recorded reporting jurisdiction counts in this 22-record cohort: Shanghai (14 records); Jiangsu (2 records).
The record-count gap between Shanghai and Jiangsu is 12, or 54.5% of this 22-record base. The gap concerns records, not revenue or market position.
| Company cohort | Directly linked pages | Share of public archive | Archive date |
|---|---|---|---|
| 22 | 22 | 0.1% | 2026-10-16 |
Deduplicated company IDs.
Counts within parent sets
| Set | All records | This subset | Excluding this subset |
|---|---|---|---|
| Biomedicine and medical devices | 1,449 | 22 | 1,427 |
| All public archive records | 19,297 | 22 | 19,275 |
Observed labels
| Dimension | Label | Count/base | Participation |
|---|---|---|---|
| reporting jurisdiction | Shanghai | 14/22 | 63.6% |
| reporting jurisdiction | Jiangsu | 2/22 | 9.1% |
| reporting jurisdiction | Inner Mongolia | 1/22 | 4.5% |
| reporting jurisdiction | Jilin | 1/22 | 4.5% |
| reporting jurisdiction | Sichuan | 1/22 | 4.5% |
| industry | Biomedicine | 17/22 | 77.3% |
| industry | Advanced materials | 3/22 | 13.6% |
| industry | Energy conservation and environmental protection | 1/22 | 4.5% |
| industry | Light industry and textiles | 1/22 | 4.5% |
Multi-label counts can overlap; filter compliance is not industrial advantage.
Evidence and list-linkage counts
| Measure | Count |
|---|---|
| Companies with existing sourced excerpts | 7/22 |
| Existing reviewed bilingual excerpt pairs | 7 |
| IDs linked to 2026 local lists | 6/22 |
| Product-field rule reminders | 2/22 |
Existing excerpts do not certify entire old reports; list linkage is not final recognition. Full definitions are on the series page.
Recorded roles and delivery checks
Related studies and shared records
| Comparison study | Reference records | Shared IDs | Focal only | Intersection/union |
|---|---|---|---|---|
| Pharmaceutical Glass Rubber Packaging Keyword Candidate Study | 7 | 3 | 19 | 11.5% |
| Shanghai / Biomedicine Company Structure Study | 147 | 12 | 10 | 7.6% |
Company samples and record links
| Company | Jurisdiction | Recorded industry |
|---|---|---|
| Shanghai Macklin Biochemical Co., Ltd. | Shanghai | Biomedicine |
| Shangke Biological Medicine (Shanghai) Co., Ltd. | Shanghai | Biomedicine |
| Bide Pharmatech Co., Ltd. | Shanghai | Biomedicine |
| Dezhou Jinghua Pharmaceutical Glass Co., Ltd. | Shandong | Biomedicine |
| Changzhou HUAJIAN Pharm Pack Material Co., Ltd. | Jiangsu | Advanced materials |
| Changchun SinoBiomaterials Co., Ltd. | Jilin | Advanced materials |
| Shanghai Opm Biosciences Co., Ltd. | Shanghai | Biomedicine |
| Nanjing Vazyme Biotech Co., Ltd. | Jiangsu | Biomedicine |
Directly related profiles and reports
| Page | Presentation |
|---|---|
| Shanghai Macklin Biochemical Co., Ltd. | Company report page |
| Shangke Biological Medicine (Shanghai) Co., Ltd. | Company data profile |
| Bide Pharmatech Co., Ltd. | Company report page |
| Dezhou Jinghua Pharmaceutical Glass Co., Ltd. | Company data profile |
| Changzhou HUAJIAN Pharm Pack Material Co., Ltd. | Company data profile |
| Changchun SinoBiomaterials Co., Ltd. | Company report page |